1. Home
  2. SONO vs VCEL Comparison

SONO vs VCEL Comparison

Compare SONO & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sonos Inc.

SONO

Sonos Inc.

HOLD

Current Price

$14.37

Market Cap

1.6B

ML Signal

HOLD

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$35.72

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SONO
VCEL
Founded
2002
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Video Chains
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.7B
IPO Year
2018
1996

Fundamental Metrics

Financial Performance
Metric
SONO
VCEL
Price
$14.37
$35.72
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$19.67
$57.75
AVG Volume (30 Days)
956.5K
674.2K
Earning Date
05-04-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
60.00
EPS
0.75
0.32
Revenue
$1,443,276,000.00
$276,259,000.00
Revenue This Year
$5.04
$19.10
Revenue Next Year
$6.53
$17.95
P/E Ratio
$18.83
$105.53
Revenue Growth
N/A
16.45
52 Week Low
$7.83
$28.95
52 Week High
$19.82
$45.97

Technical Indicators

Market Signals
Indicator
SONO
VCEL
Relative Strength Index (RSI) 59.08 58.85
Support Level $14.12 $34.26
Resistance Level $16.02 $38.48
Average True Range (ATR) 0.50 1.40
MACD 0.19 0.39
Stochastic Oscillator 83.29 98.36

Price Performance

Historical Comparison
SONO
VCEL

About SONO Sonos Inc.

Sonos Inc is an audio company dedicated to elevating life through sound, offering a connected platform that brings together music, movies, stories, and conversations. Its portfolio includes home theater speakers, components, plug-in and portable speakers and headphones, known for exceptional sound, thoughtful design, ease of use and seamless access to audio content. Its partner products and other revenue categories include accessories for home integration, such as custom-designed stands, mounts, and shelving units, along with partnerships for architectural speakers and automotive sound systems, as well as licensing, advertising revenue, and subscription-based services. The company operates in the United States and other countries, with the majority of revenue coming from the United States.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: